Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Type 2 Diabetes”

125 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 125 results

Not applicableLooking for participantsNCT05766735
What this trial is testing

Treating Early Type 2 Diabetes by Reducing Postprandial Glucose Excursions: A Paradigm Shift in Lifestyle Modification

Who this might be right for
Type 2 Diabetes
Chiara Fabris, PhD 200
Testing effectiveness (Phase 2)Looking for participantsNCT07374328
What this trial is testing

Triple Hypoglycemic Regimens In Patients With Newly Diagnosed Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes
Second Affiliated Hospital of Guangzhou Medical University 240
Not applicableStudy completedNCT03673904
What this trial is testing

High Sensitive CRP in Prediabetics and Diabetes

Who this might be right for
Assess Level of High Sensitive CRP in Diabetics and Prediabetics
Fayoum University 180
Not applicableStudy completedNCT04632849
What this trial is testing

The Use of Libre to Improve Metabolic Control and Reduce Reliance on Medication

Who this might be right for
Diabetes Mellitus, Type 2
University of Virginia 17
Post-approval studies (Phase 4)Study completedNCT01595789
What this trial is testing

The Effect of Liraglutide on the Treatment of Coronary Artery Disease and Type 2 Diabetes

Who this might be right for
Coronary Artery DiseaseDiabetes Mellitus, Type 2
Haugaard, Steen Bendix, M.D., DMSc 41
Post-approval studies (Phase 4)Study completedNCT03796975
What this trial is testing

Efficacy of Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets on the Patients With Newly Diagnosed Type 2 Diabetes Mellitus Combined With Non-alcoholic Fatty Liver Disease

Who this might be right for
Type 2 Diabetes MellitusNon-alcoholic Fatty Liver DiseaseEfficacy
Xijing Hospital 120
Post-approval studies (Phase 4)UnknownNCT04495881
What this trial is testing

Sitagliptin for the Treatment of Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Beijing Chao Yang Hospital 50
Not applicableUnknownNCT03180281
What this trial is testing

Therapies on Newly Diagnosed Type 2 Diabetes Patients With High Glucose Toxicity Which Protect Islet β Cell

Who this might be right for
Type 2 Diabetes Mellitus
First Affiliated Hospital Xi'an Jiaotong University 135
Post-approval studies (Phase 4)Study completedNCT02920801
What this trial is testing

Study About Effect of Saxagliptin on Circulating Endothelial Progenitor Cells and Endothelial Function in Newly Diagnosed Type 2 Diabetic Patients

Who this might be right for
Type 2 Diabetes Mellitus
Shanghai Zhongshan Hospital 31
Post-approval studies (Phase 4)Study completedNCT03297879
What this trial is testing

Comparison of Exenatide and Metformin Monotherapy in Overweight/Obese Patients With Newly Diagnosed Type 2 Diabetes

Who this might be right for
Type2 Diabetes
Beijing Chao Yang Hospital 230
Not applicableUnknownNCT01341795
What this trial is testing

Genetic Variation in the Transporters and Hypoglycemic Agents

Who this might be right for
Type 2 Diabetes
Ajou University School of Medicine 100
Not applicableUnknownNCT00832481
What this trial is testing

Comparison of the Effects of Repaglinide and Metformin on Glucose Excursions

Who this might be right for
Type 2 Diabetes
Chinese PLA General Hospital 60
Post-approval studies (Phase 4)Study completedNCT02252965
What this trial is testing

Metformin Extended Release Versus Metformin Immediate Release in Subjects With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Merck KGaA, Darmstadt, Germany 532
Not applicableStudy completedNCT05719675
What this trial is testing

Healthcare Intervention Program on Treatment Adherence in People With Newly Diagnosed Type 2 Diabetes Mellitus.

Who this might be right for
Treatment AdherenceQuality of LifeGlucose Metabolism Disorders (Including Diabetes Mellitus)
Universidad Nacional Autonoma de Mexico 24
Not applicableStudy completedNCT00725257
What this trial is testing

Dietary Control of Type 2 Diabetes: Low-Carbohydrate Mediterranean Diet Versus Low-Fat Diet

Who this might be right for
Type 2 Diabetes Mellitus
University of Campania Luigi Vanvitelli 215
Large-scale testing (Phase 3)WithdrawnNCT05444153
What this trial is testing

Research Study to Compare Semaglutide Tablets With Empagliflozin Tablets Taken Once Daily in People With Type 2 Diabetes and Obesity

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S
Not applicableStudy completedNCT01397279
What this trial is testing

Assessment of Liver Glucose Metabolism in Diabetic Subjects

Who this might be right for
Newly Diagnosed Type 2 Diabetes (During the Last 12 Months)
German Diabetes Center 22
Large-scale testing (Phase 3)Looking for participantsNCT07088068
What this trial is testing

Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

Who this might be right for
Type 1 Diabetes Mellitus
Sanofi 723
Not applicableEnrolling By InvitationNCT06906653
What this trial is testing

Population Health Management for KPNC Members With Newly Diagnosed Diabetes: A Randomized Trial of a Proactive and Augmented Initial Care Strategy

Who this might be right for
Type 2 DiabetesType 2 Diabetes Mellitus (T2DM)Type 2 Diabetes (T2D)
Kaiser Permanente 204
Post-approval studies (Phase 4)UnknownNCT02999841
What this trial is testing

Effect of Acarbose and Vildagliptin on Visceral Fat Distribution in Newly Diagnosed Type 2 Diabetes Patients

Who this might be right for
Diabetes Mellitus, Type 2Obesity
Peking University 100
Load More Results